Microbiome and Health Analysis – Transcriptomic Biomarkers

The microbiome plays a crucial role in human health, influencing digestion, metabolism, the immune system, and even behavior. Gene expression analysis of microbiome microorganisms helps to better understand its impact on various diseases and optimize therapeutic approaches.

Genes Analyzed in Microbiome and Health

Our panel targets key biomarkers associated with the interaction between the gut microbiome and health, including:

• 16S rRNA (bacterial genome) – Analysis of intestinal bacterial profiles to determine microbiome diversity and composition

• Firmicutes / Bacteroidetes ratio – A key indicator of microbiome balance, linked to gut health and conditions such as obesity and digestive disorders

• SCFA (Short-Chain Fatty Acids) – Short-chain fatty acids produced by fiber fermentation, influencing gut health and immune regulation

• Lactobacillus spp. – Beneficial bacteria known for their positive effects on digestion and immunity

• Bifidobacterium spp. – Important probiotics for microbiome balance and immune response modulation

• Akkermansia muciniphila – Bacteria involved in mucin degradation, associated with metabolic benefits and weight management

• Prevotella spp. – Bacteria linked to fiber-rich diets, influencing gut health and metabolism

• Fusobacterium spp. – Bacteria associated with oral health and certain digestive disorders

• Clostridium spp. – Bacteria involved in fiber fermentation and the production of beneficial gut health metabolites

• Enterococcus spp. – Microorganisms present in the intestine, playing a role in digestion and amino acid production

Applications & Benefits

• Metabolism Regulation and Weight Management – Understanding the microbiome's role in obesity, insulin resistance, and metabolic control

• Improved Digestion and Gut Health – Identifying microbiome imbalances that contribute to digestive disorders such as irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD)

• Immune System Modulation – Analyzing how microbiome bacteria influence immune response and infection prevention

• Chronic Disease Prevention – Studying the microbiome's impact on conditions such as cardiovascular diseases, hypertension, and diabetes

• Personalized Probiotic and Prebiotic Treatments – Developing targeted therapeutic strategies based on microbiome profiles for specific conditions

Technologies Used

• Genomic Sequencing (16S rRNA, Metagenomics) – Identifying and quantifying key gut microbiome bacteria

• RT-qPCR and RNA-seq (NGS) – Analyzing microbial gene expression and their interaction with the host

• Immunohistochemistry – Studying the effects of the microbiome on intestinal tissues and cells

• Metabolomics and Bacterial Culture Techniques – Investigating microbial metabolite production, such as short-chain fatty acids

Contact us at contact@genxmap.fr for a personalized microbiome analysis to optimize your treatment and prevention strategies!